• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Histone lactylation boosts bone formation in postmenopausal osteoporosis

by
November 7, 2026
in Biology
Reading Time: 3 mins read
0
Histone lactylation boosts bone formation in postmenopausal osteoporosis

Histone lactylation boosts bone formation in postmenopausal osteoporosis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers published a study in Cellular & Molecular Biology Letters demonstrating that histone lactylation plays a critical role in ameliorating postmenopausal osteoporosis. The investigation, led by Chaoqing Huang and Yuan Wang, identified a specific molecular pathway through which this epigenetic modification promotes bone formation. By stabilizing the SMAD1 protein via an IGF2BP1-dependent mechanism, the process helps counteract the bone loss typically associated with menopause. The findings offer new insights into the epigenetic factors that influence the pathogenesis of osteoporosis.

The study focused on the interplay between histone modifications and N6-methyladenosine (m6A) methylation in the context of osteoporosis. Epigenetic changes are known to affect disease progression, and RNA and histone modifications have recently attracted significant scientific attention. The authors sought to clarify the specific role of histone lactylation in this process. They utilized an ovariectomy (OVX) mouse model to simulate postmenopausal conditions and conducted in vitro experiments using osteogenic-induced bone marrow mesenchymal stem cells (BMSCs).

Initial results indicated that levels of whole lactylation and H3K18 lactylation were decreased in the OVX-induced mice. Conversely, these levels were elevated in osteogenic BMSCs, suggesting a potential link between lactylation and bone formation. To test this relationship, the researchers inhibited H3K18 lactylation using oxamate. This inhibition promoted bone defects and suppressed the osteogenic differentiation of BMSCs. When they promoted H3K18 lactylation using Nala, the opposite effects were observed, with improved bone outcomes.

The investigation further revealed that H3K18 lactylation was enriched in the promoter region of the IGF2BP1 gene. This enrichment facilitated the transcription of IGF2BP1, linking the histone modification directly to the expression of this specific protein. The study found that overexpressing IGF2BP1 attenuated the bone defects induced by OVX. In contrast, knocking down IGF2BP1 inhibited osteogenesis, highlighting the protein’s importance in maintaining bone health.

At the molecular level, IGF2BP1 was shown to recognize the m6A methylation of SMAD1. This recognition enhanced the stability of the SMAD1 protein, preventing its degradation. The researchers demonstrated that overexpressing SMAD1 could reverse the inhibition of osteogenesis and bone defects caused by silencing IGF2BP1. This suggests that the stability of SMAD1 is a key downstream effect of the IGF2BP1 pathway in bone formation.

The study concludes that histone lactylation alleviates osteoporosis by promoting osteogenesis through the transcriptional regulation of IGF2BP1. IGF2BP1, in turn, recognizes the m6A methylation of SMAD1, thereby stabilizing it. This cascade of events provides a detailed mechanism for how epigenetic modifications can influence bone biology. The findings underscore the complexity of the molecular networks involved in postmenopausal osteoporosis.

While the study provides valuable insights into the molecular mechanisms of osteoporosis, it is important to note that the research was conducted in mouse models and cell cultures.

The publication of this research contributes to the growing body of knowledge on the role of epigenetics in bone diseases. The work by Huang and Wang represents a significant step forward in understanding the intricate relationship between histone modifications and bone health.

Subject of Research: Molecular mechanisms of histone lactylation in postmenopausal osteoporosis

Article Title: Histone lactylation ameliorates postmenopausal osteoporosis by IGF2BP1-dependent SMAD1 stabilization

Article References: Huang, C., & Wang, Y. (2026). Histone lactylation ameliorates postmenopausal osteoporosis by IGF2BP1-dependent SMAD1 stabilization. Cellular & Molecular Biology Letters. https://doi.org/10.1186/s11658-026-01006-7

Image Credits: AI Generated

DOI: 10.1186/s11658-026-01006-7

Keywords: osteoporosis, histone lactylation, epigenetics, SMAD1, IGF2BP1, bone biology, postmenopausal, m6A methylation, Histone, lactylation, ameliorates, IGF2BP1-dependent

News Source: Drew Townsend. (November 7, 2026). Histone lactylation boosts bone formation in postmenopausal osteoporosis. Scienmag.

Tags: Amelioratesbone biologyepigeneticshistoneHistone lactylationIGF2BP1IGF2BP1-dependentlactylationm6A methylationosteoporosispostmenopausalSMAD1
Share12Tweet7Share2ShareShareShare1

Related Posts

Forest Conditions Outside National Parks Strongly Influence Bird Presence Within Them

Forest Conditions Outside National Parks Strongly Influence Bird Presence Within Them

November 16, 2026
Gut Microbes and Derived Toxins Drive Progression of Diabetic Kidney Disease

Gut Microbes and Derived Toxins Drive Progression of Diabetic Kidney Disease

November 16, 2026

Review Proposes Framework Linking Persistent Organic Pollutants to Sporadic Alzheimer’s Disease

November 16, 2026

Pan-Fungal Pretrained Model Prioritizes Circular RNA Candidates Without RNA Sequencing

November 16, 2026

POPULAR NEWS

  • Chaotic Encryption Scheme Secures Sensitive Image Regions Using Blurring and Scrambling

    Chaotic Encryption Scheme Secures Sensitive Image Regions Using Blurring and Scrambling

    29 shares
    Share 12 Tweet 7
  • Problematic Smartphone Use Linked to Youth Distress in Comparative Study

    29 shares
    Share 12 Tweet 7
  • Dynamo Protocol Models Single-Cell Vector Fields to Predict Lineage Fate Transitions

    29 shares
    Share 12 Tweet 7
  • Global Meta-Analysis Reveals 5.5 Percent Nontuberculous Mycobacteria Prevalence in HIV Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

SENEX Expression Promotes Apoptosis Resistance and Invasive Growth in Burkitt Lymphoma

FWB-SMOTE Algorithm Outperforms Eleven Benchmarks on Imbalanced Datasets Across Three Classifiers

Smoothing Methods Enhance Machine Learning State-of-Health Predictions for Lithium-Ion Batteries

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.